About
Dr. Valentina Agostoni joined TVM in 2020. She has hands-on experience in preclinical drug development, from hit identification to IND-enabling studies. She worked six years as a Preclinical Development Scientist for different pharmaceutical startups (Versantis, a spin-off of the ETH Zurich, and Mperia Therapeutics, a spin-off of the University of Montreal). Valentina received her PhD in Biopharmacy at the University of Paris-Saclay.
Sign up to see Dr. Valentina Agostoni's full profile
Access investment thesis, focus areas, bio, and contact details for Dr. Valentina Agostoni and 22,000+ other VC professionals.